36 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
to the minority interest in such Subsidiary) and (f) any gains or losses (less all fees and expenses chargeable thereto) attributable to any sales
424B3
nv56yy
16 Mar 07
Prospectus supplement
12:00am
DEFM14A
gzlzukyi9g
24 Jan 07
Proxy related to merger
12:00am
PRER14A
pekvabamsjm 4mzye
14 Dec 06
Preliminary revised proxy
12:00am
PREM14A
u18id2j7dl7ntx
6 Nov 06
Preliminary proxy related to merger
12:00am
POS AM
ugjav 6m10vvwf
12 Apr 06
Prospectus update (post-effective amendment)
12:00am
PREN14A
8i5ektfya i7hjz
9 Nov 05
Preliminary proxy statement filed by non-management
12:00am